According to Roche's latest financial reports the company has $19.17 Billion USD in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | $19.17 B | 53.37% |
2023-12-31 | $12.50 B | 18.24% |
2022-12-31 | $10.57 B | -25.87% |
2021-12-31 | $14.26 B | 1.94% |
2020-12-31 | $13.99 B | 14.28% |
2019-12-31 | $12.24 B | -8.21% |
2018-12-31 | $13.33 B | 8.25% |
2017-12-31 | $12.32 B | 37.82% |
2016-12-31 | $8.93 B | -3.69% |
2015-12-31 | $9.28 B | -21.59% |
2014-12-31 | $11.83 B | -12% |
2013-12-31 | $13.45 B | -12.25% |
2012-12-31 | $15.33 B | 27.42% |
2011-12-31 | $12.03 B | 3.14% |
2010-12-31 | $11.66 B | -34.96% |
2009-12-31 | $17.93 B | -9.95% |
2008-12-31 | $19.91 B | -6.84% |
2007-12-31 | $21.37 B | 6.9% |
2006-12-31 | $19.99 B | 26% |
2005-12-31 | $15.87 B | 39.26% |
2004-12-31 | $11.39 B | -12.43% |
2003-12-31 | $13.01 B | -27.36% |
2002-12-31 | $17.91 B | -35.53% |
2001-12-31 | $27.79 B | 18.89% |
2000-12-31 | $23.37 B | 9.45% |
1999-12-31 | $21.36 B | 17.49% |
1998-12-31 | $18.18 B |